Line 75: | Line 75: | ||
<body> | <body> | ||
<div class="container main"> | <div class="container main"> | ||
+ | <div class="jumbotron" style="background-image: url(https://static.igem.org/mediawiki/2016/8/89/Bielefeld_CeBiTec_2016_10_14_X_jessi2.png)"> | ||
+ | <div class="jumbotron-text"> | ||
+ | <h1 style="margin-bottom: 0px; text-align:left">Model I</h1> | ||
+ | <h2 style="color:#ffffff; text-align:left">Selection system</h2> | ||
+ | </div> | ||
+ | </div> | ||
− | |||
<div class="container text"> | <div class="container text"> | ||
Model I describes the <i>in vivo</i> <a href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System">bacterial two hybrid selection system</a>: | Model I describes the <i>in vivo</i> <a href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System">bacterial two hybrid selection system</a>: | ||
Line 88: | Line 93: | ||
" alt="Selection model" width="700 px"> | " alt="Selection model" width="700 px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 1: Selection pathway. | + | <b>Figure 1</b>: Selection pathway. |
<br> | <br> | ||
Plasmid 1 and plasmid 2 each produce one protein of the bacterial two hybrid system, respectively. When both proteins come together and bind on the DNA the reporter gene is transcribed, here beta-lactamase. The beta-lactamase then diffuses from the cytoplasm into the periplasm, where it encounters the antibiotic ampicillin and deactivates it. For detailed description see <a href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System">bacterial two hybrid system</a>. | Plasmid 1 and plasmid 2 each produce one protein of the bacterial two hybrid system, respectively. When both proteins come together and bind on the DNA the reporter gene is transcribed, here beta-lactamase. The beta-lactamase then diffuses from the cytoplasm into the periplasm, where it encounters the antibiotic ampicillin and deactivates it. For detailed description see <a href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System">bacterial two hybrid system</a>. | ||
Line 105: | Line 110: | ||
<img src="https://static.igem.org/mediawiki/2016/4/44/Bielefeld_CeBiTec_2016_10_16_Mod_chemical.png" alt="reaction sequence" width="600px"> | <img src="https://static.igem.org/mediawiki/2016/4/44/Bielefeld_CeBiTec_2016_10_16_Mod_chemical.png" alt="reaction sequence" width="600px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 2: Reaction pathway of the selection system. | + | <b>Figure 2</b>: Reaction pathway of the selection system. |
<br> | <br> | ||
The 0 stands for degeneration of proteins or complexes and the + for the interaction of two proteins or complexes. | The 0 stands for degeneration of proteins or complexes and the + for the interaction of two proteins or complexes. | ||
Line 227: | Line 232: | ||
" alt="Diffusion without active center" width="500px"> | " alt="Diffusion without active center" width="500px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 3: Diffusion of two proteins without consideration of an active centrum. | + | <b>Figure 3</b>: Diffusion of two proteins without consideration of an active centrum. |
</figcaption> | </figcaption> | ||
</figure> | </figure> | ||
Line 252: | Line 257: | ||
" alt="Diffusion with active center" width="500px"> | " alt="Diffusion with active center" width="500px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 4: Diffusion of two proteins with consideration of an active centrum. | + | <b>Figure 4</b>: Diffusion of two proteins with consideration of an active centrum. |
</figcaption> | </figcaption> | ||
</center> | </center> | ||
Line 315: | Line 320: | ||
" alt="Nitrocefin assay" width="600px"> | " alt="Nitrocefin assay" width="600px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 5: Nitrocefin assay. | + | <b>Figure 5</b>: Nitrocefin assay. |
<br> | <br> | ||
From left to right: water control and time points t0 to t6 of a <i>E. coli</i> cultivation. | From left to right: water control and time points t0 to t6 of a <i>E. coli</i> cultivation. | ||
Line 329: | Line 334: | ||
" alt="Growth curve of a culture, that carries a beta-lactamase plasmid" width="600px"> | " alt="Growth curve of a culture, that carries a beta-lactamase plasmid" width="600px"> | ||
<figcaption> | <figcaption> | ||
− | Figure 6: Growth curve of a culture, which carries a beta-lactamase plasmid. | + | <b>Figure 6</b>: Growth curve of a culture, which carries a beta-lactamase plasmid. |
</figcaption> | </figcaption> | ||
</figure> | </figure> |
Revision as of 14:18, 19 October 2016
Model I
Selection system
Model I describes the in vivo bacterial two hybrid selection system:
The selection pathway can be illustrated by the following reaction sequence:
The reaction sequence starts with the expression of the Evobody-RpoZ translational fusion construct [(a)] on the one hand and the target protein-DNA binding domain translational fusion construct [(b)] on the other hand.
Both resulting fusion proteins are degraded over time [(c)].
In the figure the degeneration is marked with a 0.
Furthermore, together with the DNA binding site for the DNA binding domain (DNABD) both fusion proteins form the bacterial two hybrid complex [(d)].
When the complex is built the RNA polymerase gets recruited and transcribes the beta-lactamase.
Just like the fusion proteins the beta-lactamase will be degraded after a while [(e)].
When the beta-lactamase and ampicillin meet in the periplasm the ampicillin will be deactivated and the cell survives.
Based on the reaction sequence the chemical reaction equations can be written down:
Based on the reaction sequence the chemical reaction equations can be written down:
(I) kexprP1 stands for the expression rate of plasmid 1, which holds the Evobody-RpoZ sequence [s-1].
kdegEvo stands for the degeneration rate of the Evobody-RpoZ protein [s-1].
(II) kexprP2 stands for the expression rate of plasmid 2, which holds the target-DNA binding domain (DNABD) protein [s-1].
kdegTarget stands for the degeneration of the target-DNABD protein [s-1].
(III) kass stands for the association rate of the bacterial two hybrid complex [(s*M)-1]. kdiss stands for the disassociation rate of the bacterial two hybrid complex [s-1].
(IV) kexprbla stands for the expression rate of beta-lactamase (bla) [s-1].
(V) ktranspbla stands for the transport rate of beta-lactamase from cytoplasm to periplasm [s-1].
(VI) kdegbla stands for the degeneration rate of the beta-lactamase [s-1].
(VII) ktranspamp stands for the transport rate of ampicillin from medium to cytoplasm and back [s-1].
(VIII) kdiff stands for the diffusion rate of beta-lactamase and ampicillin [(s*M)-1].
kdegEvo stands for the degeneration rate of the Evobody-RpoZ protein [s-1].
(II) kexprP2 stands for the expression rate of plasmid 2, which holds the target-DNA binding domain (DNABD) protein [s-1].
kdegTarget stands for the degeneration of the target-DNABD protein [s-1].
(III) kass stands for the association rate of the bacterial two hybrid complex [(s*M)-1]. kdiss stands for the disassociation rate of the bacterial two hybrid complex [s-1].
(IV) kexprbla stands for the expression rate of beta-lactamase (bla) [s-1].
(V) ktranspbla stands for the transport rate of beta-lactamase from cytoplasm to periplasm [s-1].
(VI) kdegbla stands for the degeneration rate of the beta-lactamase [s-1].
(VII) ktranspamp stands for the transport rate of ampicillin from medium to cytoplasm and back [s-1].
(VIII) kdiff stands for the diffusion rate of beta-lactamase and ampicillin [(s*M)-1].
Differential equations
Next the language of chemistry has to be translated into the language of mathematics. A system of ordinary differential equations is generated. As this system has to be solved numerically, we have chosen a notation the software package MATLAB® understands:
standexpr stands for standard expression [M].
[Evobody] or Evobody stands for Evobody-RpoZ protein [M].
[Target] or Target stands for target-DNABD protein [M].
[DNA] stands for DNA [M].
[ampPeri] stands for ampicillin in periplasm [M].
[ampMedium] stands for ampicillin in medium [M].
[blaCyt] stands for beta-lactamase in cytoplasm [M].
[blaPeri] stands for beta-lactamase in periplasm [M].
[Evobody-Target] stands for Evobody-Target protein complex [M].
[Target-DNA] stands for Target-DNA complex [M].
[Evobody-Target-DNA] stands for Evobody-Target-DNA complex [M].
kdissEvoTarget stands for disassociation rate of the Evobody-Target complex [s-1].
kassEvoTarget stand for association rate of the Evobody-Target complex [(s*M)-1].
kdissTargetDNA stand for disassociation rate of the Evobody-Target complex [s-1].
kassTargetDNA stand for association rate of the Evobody-Target complex [(s*M)-1].
kdegTarget stands for degeneration rate of the target protein [s-1].
kdegEvo stands for degeneration rate of the Evobodies [s-1].
kexprblaETD stands for the expression rate of beta-lactamase with the bacterial two hybrid complex [s-1].
[Evobody] or Evobody stands for Evobody-RpoZ protein [M].
[Target] or Target stands for target-DNABD protein [M].
[DNA] stands for DNA [M].
[ampPeri] stands for ampicillin in periplasm [M].
[ampMedium] stands for ampicillin in medium [M].
[blaCyt] stands for beta-lactamase in cytoplasm [M].
[blaPeri] stands for beta-lactamase in periplasm [M].
[Evobody-Target] stands for Evobody-Target protein complex [M].
[Target-DNA] stands for Target-DNA complex [M].
[Evobody-Target-DNA] stands for Evobody-Target-DNA complex [M].
kdissEvoTarget stands for disassociation rate of the Evobody-Target complex [s-1].
kassEvoTarget stand for association rate of the Evobody-Target complex [(s*M)-1].
kdissTargetDNA stand for disassociation rate of the Evobody-Target complex [s-1].
kassTargetDNA stand for association rate of the Evobody-Target complex [(s*M)-1].
kdegTarget stands for degeneration rate of the target protein [s-1].
kdegEvo stands for degeneration rate of the Evobodies [s-1].
kexprblaETD stands for the expression rate of beta-lactamase with the bacterial two hybrid complex [s-1].
Diffusion
The deactivation reaction of ampicillin through beta-lactamase is a diffusion-controlled reaction. An equation that considers the rate at which the reactants diffuse is needed [Atkins and De Paula, 2010]:
This equation describes the general diffusion of two molecules (figure 3).
But in our case the enzyme beta-lactamase only reacts with ampicillin, if its active centrum is in close proximity to ampicillin (figure 4 B).
When beta-lactamase and ampicillin meet correctly, ampicillin is deactivated as shown in figure 4, section B to D. Section E indicates a wrong encounter of beta-lactamase and ampicillin.
That's why we decided to modify the equation according to [Bisswanger, 2004]:
Rmin is defined as the distance in which the two reactant molecules, here ampicillin and beta-lactamase, react. This is the case, when they are in very close proximity. D is the sum of the diffusion coefficients of the two reactants in the solution. In our case the solution is the periplasm. The term diffusion describes the movement of a substance in a solution; the bigger the diffusion coefficient, the larger the diffusion velocity.
The angle α restricts the reaction area of the enzyme to its active center (see opening in figure 4). So a reaction between beta-lactamase and ampicillin only takes place, when ampicillin meets the active center of beta-lactamase.
Finally, the equation for the diffusion rate kdiff must be multiplied with the Avogadro constant NA to gain the unit [(s*M)-1].
Rmin was computated under the assumption that beta-lactamase and ampicillin react when they are in close vicinity and that the molecules are nearly spherical. Therefore, the minimal radius of a sphere that could contain the given mass of protein was estimated using the formula from [Erickson, 2009]:
Finally, the equation for the diffusion rate kdiff must be multiplied with the Avogadro constant NA to gain the unit [(s*M)-1].
Rmin was computated under the assumption that beta-lactamase and ampicillin react when they are in close vicinity and that the molecules are nearly spherical. Therefore, the minimal radius of a sphere that could contain the given mass of protein was estimated using the formula from [Erickson, 2009]:
for V in nm3, M in Dalton and Rmin in nanometer.
For beta-lactamase we obtained 2.0277 nm and for ampicillin 0.4649 nm.
To compute the diffusion coefficients we used the program WinHydroPro v1.00 PUB [Ortega, 2011]. We received 2.852*10-9 for beta-lactamase and 1.237*10-8 for ampicillin. The angle α was computed with the open-source program PyMOL [PyMOl, 2013]. α was determined to be 25°. In the end we computed the reproduction rate in dependence of the ampicillin concentration in the periplasm, adapting the formula of Potsdam's:
For beta-lactamase we obtained 2.0277 nm and for ampicillin 0.4649 nm.
To compute the diffusion coefficients we used the program WinHydroPro v1.00 PUB [Ortega, 2011]. We received 2.852*10-9 for beta-lactamase and 1.237*10-8 for ampicillin. The angle α was computed with the open-source program PyMOL [PyMOl, 2013]. α was determined to be 25°. In the end we computed the reproduction rate in dependence of the ampicillin concentration in the periplasm, adapting the formula of Potsdam's:
where n is the ampicillin concentration in periplasm. The time point 20 minutes was chosen, because the division rate of an E. coli cell is around 20 minutes.
Experimental validation
A theoretically implemented model must always be validated with experimentally measured data.
Therefore, we designed and conducted an amount of appropriate experiments.
Firstly, we performed a beta-lactamase PCA colorimetric assay, and, secondly, a cultivation experiment. The cultivation experiment was used to measure the beta-lactamase concentration with the Nitrocefin assay over time. The experiments were essential to adapt model I.
Beta-lactamase PCA colorimetric assay
To quantify the amount of active beta-lactamase in the periplasm of an E. coli bacterium and thus validate our mathematical program in this aspect, we performed an [osmotic shock] and a [beta-lactamase PCA colorimetric assay] [André Galarneau et. al, 2002]. The osmotic shock leads to the disruption of the periplasm and spreading of membrane proteins. To yield the maximum amount of active beta-lactamase an osmotic shock is used that does not use detergents that are harmful for the activity of beta-lactamase [Jalalirad, 2013]. With the beta-lactamase PCA colorimetric assay we determined the amount of beta-lactamase through the reduction of Nitrocefin. When Nitrocefin is split by beta-lactamase it changes its color from yellow to red like in figure 5. To measure how the beta-lactamase production changes over time we cultivated E. coli with a beta-lactamase plasmid for 6 hours and took probes every hour. Afterwards we did a lysis and a Nitrocefin assay. The results can be seen here:
In figure 5 it can be seen that the beta-lactamase concentration rises with proceeding cultivation. Also we measured the beta-lactamase concentration of the whole culture at every time point and computed with the use of the OD (figure 6) the beta-lactamase concentration for one cell. 1 OD is converted to 8 * 108 cells. One cell comprises around 1.27848 * 10-6 M beta-lactamase in the periplasm. We adapted our system accordingly.